In a report released today, Bob Huang from Morgan Stanley maintained a Buy rating on Metlife (MET – Research Report), with a price target of ...
Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $98 from $100 and keeps an Outperform rating on the shares.Maximize Your ...
Through a collaboration with TELUS Health, New Hampshire employees enrolled in an employer-sponsored plan now have access cognitive behavioral therapy services.
MetLife Inc. closed 6.70% short of its 52-week high of $89.05, which the company reached on November 27th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results